Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p71
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 71/381)
Character Range: 11977723–11987525

other anti-epileptic drugs; AND
                                                                                                                                                                    Must be treated by a neurologist if treatment is being initiated.  or
                                                                                                                                                                    Must be treated by a neurologist if treatment is being continued or re-initiated.  or
                                                                                                                                                                    Must be treated by a paediatrician in consultation with a neurologist if treatment is being continued.  or
                                                                                                                                                                    Must be treated by a general practitioner in consultation with a neurologist if treatment is being continued.
C11683              P11683         CN11683          Clonazepam                                                                                                      For use in patients receiving palliative care

                                                    Haloperidol

                                                    Metoclopramide

C11696              P11696         CN11696          Fentanyl                                                                                                        Severe disabling pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures
                                                                                                                                                                    Patient must not be opioid naive; AND
                                                    Methadone                                                                                                       Patient must have had or would have inadequate pain management with maximum tolerated doses of non-opioid and other opioid analgesics; or
                                                                                                                                                                    Patient must be unable to use non-opioid and other opioid analgesics due to contraindications or intolerance; AND
                                                                                                                                                                    Patient must be undergoing palliative care.
C11697              P11697         CN11697          Hydromorphone                                                                                                   Severe pain                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Compliance with Authority Required procedures - Streamlined Authority Code 11697
                                                                                                                                                                    Patient must have had or would have inadequate pain management with maximum tolerated doses of non-opioid and other opioid analgesics; or
                                                    Morphine                                                                                                        Patient must be unable to use non-opioid and other opioid analgesics due to contraindications or intolerance; AND
                                                                                                                                                                    Patient must be undergoing palliative care.
C11704              P11704         CN11704          Adalimumab                                                                                                      Severe Crohn disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Compliance with Written Authority Required procedures
                                                                                                                                                                    First continuing treatment
                                                                                                                                                                    Must be treated by a gastroenterologist (code 87); or
                                                                                                                                                                    Must be treated by a consultant physician [internal medicine specialising in gastroenterology (code 81)]; or
                                                                                                                                                                    Must be treated by a consultant physician [general medicine specialising in gastroenterology (code 82)]; AND
                                                                                                                                                                    Patient must have received this drug as their most recent course of PBS-subsidised biological medicine treatment for this condition; AND
                                                                                                                                                                    Patient must have an adequate response to this drug defined as a reduction in Crohn Disease Activity Index (CDAI) Score to a level no greater than 150 if assessed by CDAI or if affected by extensive small intestine disease; or
                                                                                                                                                                    Patient must have an adequate response to this drug defined as (a) an improvement of intestinal inflammation as demonstrated by:
                                                                                                                                                                     (i) blood: normalisation of the platelet count, or an erythrocyte sedimentation rate (ESR) level no greater than 25 mm per hour, or a C-reactive protein (CRP) level no greater than 15 mg per L; or (ii) faeces: normalisation of lactoferrin or calprotectin level; or (iii) evidence of mucosal healing, as demonstrated by diagnostic imaging findings, compared to the baseline assessment; or (b) reversal of high faecal output state; or (c) avoidance of the need for surgery or total parenteral nutrition (TPN), if affected by short gut syndrome, extensive small intestine or is an ostomy patient; AND
                                                                                                                                                                    Patient must not receive more than 24 weeks of treatment under this restriction;
                                                                                                                                                                    Patient must be aged